|
Re: Deja Vu All Over Again
|
6
|
Resverlogix Corp.
|
Mar 13, 2022 12:56PM
|
|
Re: Debenture Due Friday the 13th, May 2022
|
5
|
Resverlogix Corp.
|
Mar 07, 2022 03:14AM
|
|
Re: Currency
|
2
|
Resverlogix Corp.
|
Nov 05, 2015 08:49AM
|
|
Re: Currency
|
3
|
Resverlogix Corp.
|
Nov 05, 2015 09:36AM
|
|
Re: Currency
|
2
|
Resverlogix Corp.
|
Nov 05, 2015 10:37AM
|
|
Re: Crazy Question
|
2
|
Resverlogix Corp.
|
Jan 06, 2024 01:10PM
|
|
Re: Cost of Dilution/Public Offering v Private Placement
|
2
|
Resverlogix Corp.
|
Oct 08, 2020 10:19AM
|
|
Re: Cost of Dilution/Public Offering v Private Placement
|
4
|
Resverlogix Corp.
|
Oct 08, 2020 12:41PM
|
|
Re: Cost of Dilution/Public Offering v Private Placement
|
5
|
Resverlogix Corp.
|
Oct 08, 2020 06:23PM
|
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
6
|
Resverlogix Corp.
|
Apr 15, 2021 04:40PM
|
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
4
|
Resverlogix Corp.
|
Apr 15, 2021 06:08PM
|
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
5
|
Resverlogix Corp.
|
Apr 15, 2021 03:06PM
|
|
Re: Contest Tally
|
1
|
Resverlogix Corp.
|
Feb 12, 2019 08:39PM
|
|
Re: Connecting the Dots II - Royalty Preferred Shares
|
2
|
Resverlogix Corp.
|
Feb 17, 2019 12:21PM
|
|
Re: Connecting the Dots II - Royalty Preferred Shares
|
2
|
Resverlogix Corp.
|
Feb 17, 2019 12:40PM
|
|
Re: Connecting the Dots II - Royalty Preferred Shares
|
3
|
Resverlogix Corp.
|
Feb 17, 2019 03:14PM
|
|
Re: Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid
|
7
|
Resverlogix Corp.
|
Jun 02, 2022 01:27PM
|
|
Re: Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid
|
4
|
Resverlogix Corp.
|
Jun 02, 2022 03:22PM
|
|
Re: Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid
|
4
|
Resverlogix Corp.
|
Jun 02, 2022 03:25PM
|
|
Re: Close at $2.47.....print it
|
2
|
Resverlogix Corp.
|
Oct 05, 2016 10:24PM
|
